| TTM
|
3/31/2026
|
3/31/2025
|
3/31/2024
|
3/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
160,749,000 | 151,851,000 | 129,537,000 | 126,718,000 | 121,341,000 |
| Cost of Revenue
|
-123,467,000 | -116,480,000 | -98,835,000 | -98,904,000 | -94,485,000 |
|
Gross Profit
|
37,281,000 | 35,371,000 | 30,702,000 | 27,814,000 | 26,855,000 |
|
Operating Income/Expenses
|
-17,770,000 | -17,091,000 | -16,479,000 | -15,141,000 | -12,795,000 |
|
Total Operating Profit/Loss
|
19,511,000 | 18,280,000 | 14,223,000 | 12,673,000 | 14,060,000 |
| Total Net Finance Income/Expense
|
-497,000 | -453,000 | -306,000 | -228,000 | -190,000 |
| Irregular Income/Expenses
|
17,000 | 2,000 | -6,000 | -14,000 | -4,773,000 |
|
Other Income/Expense, Non-Operating
|
2,000 | -26,000 | -42,000 | -126,000 | -46,000 |
|
Non-Operating Income/Expenses, Total
|
-478,000 | -477,000 | -354,000 | -368,000 | -5,009,000 |
|
Pretax Income
|
19,036,000 | 17,802,000 | 13,870,000 | 12,305,000 | 9,051,000 |
| Provision for Income Tax
|
-5,746,000 | -5,332,000 | -4,319,000 | -3,808,000 | -2,959,000 |
|
Net Income from Continuing Operations
|
13,290,000 | 12,470,000 | 9,551,000 | 8,497,000 | 6,092,000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
13,291,000 | 12,470,000 | 9,550,000 | 8,497,000 | 6,091,000 |
|
Net Income after Non-Controlling/Minority Interests
|
13,291,000 | 12,470,000 | 9,550,000 | 8,497,000 | 6,091,000 |
|
Net Income Available to Common Stockholders
|
13,291,000 | 12,470,000 | 9,550,000 | 8,497,000 | 6,091,000 |
|
Diluted Net Income Available to Common Stockholders
|
13,291,000 | 12,470,000 | 9,550,000 | 8,497,000 | 6,091,000 |
| Basic EPS
|
169.89 | 159.43 | 122.22 | 109.23 | 78.66 |
| Diluted EPS
|
169.84 | 159.37 | 122.12 | 108.74 | 77.99 |
|
Basic Weighted Average Shares Outstanding
|
78,233.21 | 78,220.08 | 78,143.22 | 77,789.98 | 77,434.53 |
|
Diluted Weighted Average Shares Outstanding
|
78,257 | 78,245.59 | 78,201.77 | 78,140.52 | 78,099.76 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
19,533,000 | 18,255,000 | 14,176,000 | 12,533,000 | 9,241,000 |
|
EBITDA
|
18,370,000 | 18,370,000 | 14,278,000 | 12,584,000 | 9,476,000 |
|
Normalized EBITDA
|
18,435,000 | 18,435,000 | 14,339,000 | 12,643,000 | 14,282,000 |
|
Normalized Income
|
13,278,131.43 | 17,809,000 | 13,876,000 | 12,321,000 | 13,833,000 |
|
Total Unusual Items
|
-17,000 | 65,000 | 61,000 | 59,000 | 4,806,000 |
|
Total Unusual Items Excluding Goodwill
|
-17,000 | 65,000 | 61,000 | 59,000 | 4,806,000 |
|
Tax Effect of Unusual Items
|
-5,131.43 | 19,468.61 | 18,994.85 | 18,258.61 | 1,571,562 |
|
Tax Rate, Calculated
|
0.30 | 0.30 | 0.31 | 0.31 | 0.33 |
3/31/2023 - 2/3/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade